EUCTR2019-002529-31-NO进行中（未招募）1 期
SAFETY AND EFFICACY OF SHINGRIX VACCINATION IN VARICELLA NAÏVE RENAL TRANSPLANT RECIPIENTS
Oslo University Hospital0 个研究点目标入组 50 人开始时间: 2019年12月11日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Kidney Transplant recipients
- •VZV IgG sero-negative
- •Age > 18 years
- •Stable renal function
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 30
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 20
排除标准
- •Any acute rejection episode < 3 months prior to inclusion
- •Evidence of previous clinical Varicella or Herpes Zoster infection
- •Reveived a VZ vaccination dose within 12 months preceding the first study dose
- •History of severe allergic reaction , such as anaphylaxis, to any Component of the vaccine
- •Pregnant women or women who are breastfeeding
- •In cases of moderate or seriuos acute illness, the vaccination should be postponed until the patient has recovered
研究者
相似试验
招募中
1 期
Safety and immunologic response of SHIngrix VAccination in patients suffering from Psoriasis or Psoriatic arthritis (SHIVAP)Psoriasis vulgaris and/or psoriatric arthritisMedDRA version: 20.0Level: LLTClassification code 10050576Term: Psoriasis vulgarisSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersMedDRA version: 21.0Level: LLTClassification code 10037160Term: Psoriatic arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2022-003477-36-DEJustus-Liebig University Giessen - KKS Marburg-Giessen336
进行中（未招募）
4 期
To determine if the Shingrix vaccine is immunogenic for people living with HIV who are aged 50 and over or have perinatally acquired HIV infection and are aged 18 or overHerpes zoster (shingles) in people living with HIVInfections and InfestationsISRCTN34192276Guy's and St Thomas' NHS Foundation Trust70
已完成
2 期
Efficacy and safety of live varicella vaccine in patients with diabetes mellitus associated with decreased cell-mediated immunity: a Randomized, Double-blind, Placebo-controlled Trialdiabetes mellitusJPRN-UMIN000018879Kitano hospital, The Tazuke Kofukai Medical Research Institute80
已完成
不适用
Efficacy and safety of vaccination of the influenza A (H5N1) Egyptian strain, and searching for the optimal intervals of the primary vaccination.Prevention of influenzaJPRN-UMIN000011799Clinical Research Center, National Hospital Organization140
进行中（未招募）
不适用
Evaluation of the effectiveness of vaccination with 2009 H1N1 vaccines during influenza season 2010-112009 H1N1-influenssarokotteiden tehokkuus influenssakaudella 2010-11 - Pandemiarokotuskampanjan jatkotutkimusInfluenza caused by the 2009 H1N1 influenza virus (swine influenza)MedDRA version: 12.1Level: LLTClassification code 10022001Term: Influenza (epidemic)EUCTR2010-021033-30-FIational Institute for Health and Welfare3,000